Competition in the generics sector is increasing demand for technologies that can manufacture large volume drug products faster and more efficiently. There is demand for everything from better powder flow and containment systems through to faster fill, finish and packaging technologies.

 

     In addition, the small molecule drug sector’s desire to differentiate its products - for example by employing modified release systems – has increased demand for systems capable of manufacturing such formulations. Examples include various extrusion, spray drying and blending technologies. Pharma interest in continuous manufacturing is also an opportunity for technology developers. There is particular demand for systems with enhanced connectivity and monitoring capacity.

 

     The emergence of the personalised medicines and cell and gene therapy sectors has also created demand for technology innovation. Modular technologies with reduced footprints are best suited to the smaller production runs that are characteristic of personalised medicines. In addition, AI systems have a role to play in the enhanced process monitoring and data management that the production of such therapies requires.